The antimicrobial potential of cranberry hydro alcoholic extracts (CrE) was evaluated against Escherichia coli isolated from women with urinary tract infection (UTI). CrE was diluted based on the percentage of proanthocyanidins (PACs) in extract powder for final concentrations: 1.26%; 2.52%; 3.35%, 5.03% and 10.06%. CrE antimicrobial potential was evaluated by disk and well diffusion assays, and by in vitro direct action against E. coli. Antibacterial action was observed for all performed tests: the minimal inhibitory concentration (MIC) was 1.26% PACs per disk diffusion assay and 2.52% of PACs by well diffusion assay.
Introduction
It is estimated that around 150 million urinary tract infections (UTIs) occur worldwide each year. The average is 8 million cases in the United States alone. Urinary infection is the most common bacterial infection among adult women and active sex life [1] reaching between 50% and 60% throughout their lives [2] .
E. coli stands out as the main etiological agent, with a percentage of occurrence of 75 to 95% of the clinical isolates of UTIs [3, 4] . In women the recurrence of infection is common, mainly due to the anatomy of the Revista Fitos, Rio de Janeiro. 2019; 13(4): 278-288 | e-ISSN: 2446-4775 | www.revistafitos.far.fiocruz.br | CC-BY 4.0
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Chiavini, Gelinski, Locatelli e Costa urethra, in addition to other factors associated with the use of contraceptives, menopause [4] , diarrhea or antifungals [5] . According to Strasinger & Lorenzo [6] , UTIs are of different proportions, and can be characterized as: cystitis, a bacterial infection with inflammation in the ascending part of the bladder or lower urinary tract; an acute pyelonephritis or even a chronic pyelonephritis, causing renal structures abnormalities. UTIs are considered to be recurrent when two or more infections occur within a period of six or more than three months in a period of one year after curing of first infection [7, 8] .
In the United States of America, 11% of women over 18 years of age will have a bladder infection per year.
Cystitis tends to be recur, unlike pyelonephritis and other types of UTIs [9] . Repeated treatment is also associated with increased resistance mechanisms against β-Lactams and fluoroquinolones [10] .
The fruit cranberry (Vaccinium macrocarpon L) is a native fruit of North America, with records of cultivation around 1816. The fruit was described by North American Indians who used it for the treatment of UTIs [4, 11] .
Cranberry fruit has water, organic acids, fructose, vitamin C, flavonoids, anthocyanins, catechins, triterpenes, glycosides, anthocyanidins and proanthocyanidins (PACs). PACs are tannins that inhibit bacterial adhesion, constituting a system of natural defense of the plant [4, 11] .
Adherence to uroepithelium is the first step for the bacterium to develop an infection and this ability is determined by the electrical charge of the surface of the microorganism, hydrophobicity, fimbriae and adhesins [11] [12] [13] . The adhesins bind the exposed lectins to the host cells, where they adhere, multiply and cause infection [3, 4, 11] . Research indicates that the beneficial effect of cranberry on UTIs [14] occurs by blocking adhesion of E. coli to uroepithelium and therefore inhibit urinary infection [15] . Without bacterial adhesion, colonization does not occur in urinary tract [4, 11] .
In general, when a patient presents a probable UTI, the bacterium has already ascended the urethra towards the bladder, colonizing, multiplying and causing inflammation and severe pain [16] . Although indicators point to a decrease in E. coli adhesion after eight hours of cranberry intake, studies are still lacking to prove its effectiveness, metabolism, excretion, and protective action against UTIs [4] . It is possible that cranberry extract works as a coadjuvant in the prevention or treatment of diseases, especially related to UTIs [17, 18] .
However, the efficacy of prophylaxis with cranberry has not yet been confirmed. Several studies have shown that urinary tract infections are a public health problem, as well as being a frequent infection, especially in women, it can become repetitive as well as the use of antibiotics. In addition, hospitals are increasingly crowded, compromising treatment against bacterial resistance.
In view of the above, this study evaluated the antimicrobial potential of cranberry hydroalcoholic extract on E. coli strains get from women with urinary infection and residents in a rural community of Santa Catarina state, Brazil. 
Materials and methods

Bacterial isolates and biochemistry confirmation
Bacterial clinical isolates nitrate positive and suggestive of Escherichia coli were obtained of urine. For each bacterial isolate, the Bactray system (Laborclin, São Paulo) was used for the biochemical identification of Gramnegative bacilli, oxidase-negative and glucose assimilation profile. Previously, Methylene Blue and Eosine agar (EMB, HiMedia Laboratories Pvt., India) was used for all typical E. coli isolates. The cultures were then maintained in standard Brain Heart Infusion agar (BHI, Difco, Brazil) for antimicrobial activity testing.
Preparation of Cranberry Extract
We used the dried extract of the fruit cranberry (Vaccinium macrocarpon L.) (Fagron, Holland) in the form of fine powder, colour reddish brown, with characteristic odor. The physics, chemistry and microbiological quality control data were evaluated according to the Manufacturing lot (code CMYJ20150102). The extraction solvent was ethanol/water (1:1) with estimated initial concentration of 25.16% proanthocyanidins.
Five different concentrations of the hydroalcoholic extract (ethyl alcohol PA: H20, 1: 1) of cranberry were prepared from stock solution corresponding to following percentage of proanthocyanidins (1:1): (25.16%), 1: 2.5: (10.06%), 1: 5: (5.03%), 1: 7.5: (3.35%), 1: 10: (2.52%) and 1: 20: (1.26%). The extracts were sterilized by membrane filtration (Millipore™, pore Ф 0.45 μm). These concentrations were determined based on the total percentage of proanthocyanidins contained in the sample. Therefore, the objective was to determine the lowest concentration capable of inhibiting E. coli.
Bacterial culture and tests
For each test performed, the bacterial isolates were reactivated in BHI broth for 18-24 hours. Culture aliquots were inoculated into BHI agar (Difco, Brazil) for isolating colonies after incubation at 35°C/24 hours. When necessary, BHI broth cultures of 18 h/35°C were also obtained for using liquid culture in log phase of growth.
An inoculum with 1.5x10 6 CFU.mL -1 were used for disk or well diffusion tests.
Antimicrobial susceptibility by Escherichia coli isolates
The antimicrobial susceptibility profile (antibiogram) of clinical E. coli isolates was evaluated based on the disc diffusion technique according to the BrCAST (Brazilian Committee on antimicrobial susceptibility testing [18] . Were used: THE antibiotics (Cefar, São Paulo): Amikacin (30 μg), Amoxicillin/clavulanic acid (20 μg), Ampicillin (10 μg), Cephalotin (30 μg), Cefepime (30 μg), Ceftriaxone 30μg), Ciprofloxacin (5 μg), Gentamicin (10 μg), Piperacillin/azobactam (100 μg) and Trimethoprim/Sulfamethoxol 25/23.75 μg).
Antimicrobial activity
The indirect antimicrobial activity of cranberry extracts was evaluated based on well diffusion and disk diffusion assays:
Well diffusion (WD) assay [19] -cultures previously grown from each of the E. coli isolates in BHI broth were inoculated in plate (20 μL) in sterile Petri dish, adding 20 mL of 1% tryptone agar (Difco, Brazil). After agar solidification, the wells were perforated in agar and adding 35 μL of the respective dilutions of cranberry the Disk diffusion (DD) -all clinical isolates of E. coli were previously developed on BHI agar (18-24 hours 37°C) for use in disk diffusion inhibition tests. The tests were realized according to the CLSI methodology (Clinical and Laboratory Standards Institute) using Mueller Hinton agar [19] . Sterile disks of 6.33 mm in diameter (Cefar, 
Results and Discussion
Clinical records of recurrent urinary tract infections (UTIs)
Were analysed 2.550 medical records of data obtaining during 4 years. Of these, 799 urine cultures were performed. It was found that 66 female patients (all age groups) had Urinary tract infection (UTI) in that period. Of these, 51 women were of childbearing age. Several bacterial species were present in different percentages. E. coli was present in 62.9% of these urinary infections and, on average, 3 infections occurred for each patient over four years (TABLE 1) . Enterococcus sp. presented the second highest percentage 
Antimicrobial susceptibility
Since E. coli are increasingly involved in mechanisms of resistance against β-lactams and fluoroquinolones [20] , in this study, the antibiotic susceptibility profile was evaluated for each of the nine strains of E. coli (TABLE 3) 
Proanthocyanidins (PACs) in cranberry hydroalcoholic extract/mean values of inhibition diameter halos (ɸ, mm) in agar diffusion assay
Antimicrobial activity by well and disk diffusion tests by using hydroalcoholic extract of cranberry
The isolates were submitted to well diffusion and disk diffusion tests with the six concentrations of PACs 
Direct in vitro antimicrobial activity of cranberry hydroalcoholic extract
The direct in vitro inhibition tests against microbial cells can provide more real data on the inhibitory potential of substances, since quantification of the population resulting from the action of the test substance on the untreated group (TABLE 5) . E. coli has been confirmed as the main etiologic agent of UTI (occurrence of 75 to 95%) [3, 4] . We verify about 62.9% of UTI of female patients. This shows that in that rural municipality of the Midwest of Santa In general, studies related to cranberry evaluate bacterial inhibition using E. coli Type 1 and its fimbria-P.
This is a protein filament that allows adhesion to the bladder epithelium of the host [4] . Even though E. coli type 1 is most implicated in urinary tract infections, other species have also been isolated, such as Proteus sp., Pseudomonas aeruginosa, Enterococcus faecalis, Staphylococcus aureus, such as here in which was isolated a strains of Hafnia sp. [9, [20] [21] [22] [23] [24] .
Urinary tract infections are a big problem, not just by frequency but also by becoming recurrent or repetitive.
Recurrent urinary tract infections (UTIr) are characterized by the occurrence of two or more episodes in six months, or three or more episodes per year after the first UTI has been cured [8] . A study conducted in the USA demonstrated the increase in bacterial resistance of E. coli to some antibiotics over a 10-year period.
The bacteria acquired an increase of 14.1% for Ciprofloxacin and for Trimethoprim / Sulfamethoxazole an increase of 6.3%. Other antibiotics did not increase significantly, such as Amoxicillin/Clavulanic acid (increase of 0.3%) and Nitrofurantoin (increase of 0.8%). In this study, two bacteria were resistant to Ciprofloxacin and two to Trimethoprim/Sulfamethoxazole.
In our study the isolate no. 5 of E. coli was resistant at least six antibiotics. Thus, it can be considered as multidrug resistant, and a concern for women with UTI´s. The data indicated a direct action of the CrE in culture which was able to eliminate the population in relation to the control group after 2 hours. Therefore, CrE was efficient in eliminating the multiresistant strain.
The indiscriminate use of antimicrobials is worrying. But it does not rule out the need of developing new drugs for prevention, treatment or prophylaxis of these UTIs [20] . Informally, cranberry extract has been indicated as a prophylactic agent related to UTIs. The activity of bacterial inhibition in vitro has been evaluated based on the ability of adhesion to host cells. Thus, Lavigne et al. [22] analyzed bacterial antiadhesion activity in vitro using urine from healthy patients experimentally contaminated with different strains of E. coli. In that study, there was an in vitro anti-adhesion effect with urine samples from patients treated with three 108 mg/day (group 1) capsules compared to the placebo group (group 2). Study realized by using the concentrations of PACs of 0.64, 128 and 345.8 mg. mL -1 were used in the co-culture of E. coli with human uroepithelial cells. Thus, it was observed in vitro inhibition of bacterial adhesion [23] . The antimicrobial direct action of the CrE (dilution 1: 2.5) corresponding to the dose of cranberry extract marketed in capsules (approximately 400 mg/capsule) showed elimination of the population after the treatments. However, about 5.03% of PACs (approx. 200 mg/capsule) also was used and it was considered more adequate to evaluate the real power of direct in vitro inhibition of the extract on E. coli. Furthermore, it has a better cost-benefit ratio. As a result, there was a total reduction in the number of colonies for two of the strains and inhibition of the others in relation to the initial concentration of microorganisms of each control group.
The resistance to antimicrobials derived from plants is considered low [24, 25] . This drives studies on the antimicrobial potential of plant extracts [26, 27] . Côté et al. [25] At the present study the mean of inhibition halo was 12.33 mm for 25.16% of PACs by using cranberry extract in well diffusion assay. It is known that the action of tannins on bacterial membranes occurs mainly by the chelation of metallic ions [21] . Cranberry is rich in condensed tannins (PACs) [3, 4, 11] and possibly the mechanism of inhibition of cranberry is the same, since the PACs are condensed tannins [4, 11] .
Here, there was no inhibition difference between the concentrations of 25.16% and 10.06% of PACs, and it occurred even at the lowest concentration, i.e., 1.26% of PACs. Cranberry extract was more inhibitory than the antibiotics Ceftazidime and Cefotaxime, used as controls (positive). This indicates a great inhibition potential.
Only for the concentrations 1.26%, 2.52% and 3.45% of PACs the inhibition of Escherichia coli by cranberry extract was dose-dependent, i.e directly proportional to the concentration of PACs. Cranberry extract was more efficient at eliminating one of the multi-resistant antibiotic isolates than any of the antibiotic tested. The results indicate a great inhibitory action potential of the cranberry extract. However, additional in vitro e also in vivo analysis may be performed to determine the best concentration of cranberry extract capable of having a real beneficial effect on UTI´s. In addition, studies of the mechanisms of action of PACs on E. coli can help to understand better the process of bacterial adhesion in urinary infections.
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